Robert Mannel to Neoplastic Cells, Circulating
This is a "connection" page, showing publications Robert Mannel has written about Neoplastic Cells, Circulating.
Connection Strength
0.092
-
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 2011 Oct; 123(1):19-26.
Score: 0.092